XBI icon

SPDR S&P Biotech ETF

756 hedge funds and large institutions have $9.15B invested in SPDR S&P Biotech ETF in 2024 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 252 increasing their positions, 254 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

less funds holding

Funds holding:

6% less capital invested

Capital invested by funds: $9.75B → $9.15B (-$594M)

22% less funds holding in top 10

Funds holding in top 10: 2318 (-5)

46% less call options, than puts

Call options by funds: $1.59B | Put options by funds: $2.95B

Holders
756
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
18
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.59B
Puts
$2.95B
Net Calls
Net Calls Change

Top Buyers

1 +$415M
2 +$192M
3 +$151M
4
Bank of America
Bank of America
North Carolina
+$124M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$33.6M

Top Sellers

1 -$172M
2 -$145M
3 -$136M
4
ACA
Avoro Capital Advisors
New York
-$117M
5
Morgan Stanley
Morgan Stanley
New York
-$82.6M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$55.5M
27
$52.1M
28
$42M
29
$41.9M
30
$41.3M
31
$35.2M
32
$33.7M
33
$33M
34
$29.8M
35
$27.9M
36
$26.5M
37
$25M
38
$24.9M
39
$24.8M
40
$24.2M
41
$23.8M
42
$22.8M
43
$22.7M
44
$22.6M
45
$22.4M
46
$22.1M
47
$21.6M
48
$21.4M
49
$20.7M
50
$19.8M